Trade Corbion N.V. - CORB CFD

Add to favourite

18.595

0.05%

0.280

Low: 18.595

High: 18.825

Market Trading Hours* (UTC) Opens on Thursday at 07:00

Mon - Fri: 07:00 - 15:30

Summary
Historical Data
Events
Income Statement
Balance Sheet
Cash Flow

Trading сonditions

Spread

0.280

Long position overnight fee

-0.022102%

Short position overnight fee

-0.000121%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

EUR

Margin

Stock exchange

Netherlands

Commission on trade

*Information provided by Capital.com

Corbion NV ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats

Prev. Close*	18.585
Open*	18.715
1-Year Change*	-37.42%
Day's Range*	18.595 - 18.825
52 wk Range	14.54-37.76
Average Volume (10 days)	68.84K
Average Volume (3 months)	2.46M
Market Cap	1.06B
P/E Ratio	15.89
Shares Outstanding	59.27M
Revenue	1.51B
EPS	1.12
Dividend (Yield %)	3.13725
Beta	1.04
Next Earnings Date	Mar 1, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 17, 2024	18.595	0.010	0.05%	18.585	18.915	18.565
Apr 16, 2024	18.585	0.090	0.49%	18.495	18.745	18.395
Apr 15, 2024	18.805	-0.380	-1.98%	19.185	19.235	18.725
Apr 12, 2024	19.085	-0.550	-2.80%	19.635	19.695	18.955
Apr 11, 2024	19.445	-0.140	-0.71%	19.585	20.030	19.445
Apr 10, 2024	19.665	-0.170	-0.86%	19.835	20.530	19.645
Apr 9, 2024	19.755	0.290	1.49%	19.465	19.795	19.085
Apr 8, 2024	19.635	0.060	0.31%	19.575	19.755	19.475
Apr 5, 2024	19.575	-0.330	-1.66%	19.905	19.905	19.395
Apr 4, 2024	19.835	-0.125	-0.63%	19.960	20.090	19.695
Apr 3, 2024	19.885	-0.020	-0.10%	19.905	19.970	19.545
Apr 2, 2024	19.855	-0.115	-0.58%	19.970	20.150	19.655
Mar 28, 2024	19.905	0.080	0.40%	19.825	20.070	19.495
Mar 27, 2024	19.745	-0.135	-0.68%	19.880	20.010	19.655
Mar 26, 2024	19.950	0.040	0.20%	19.910	20.090	19.775
Mar 25, 2024	20.030	0.705	3.65%	19.325	20.110	18.995
Mar 22, 2024	19.445	-0.040	-0.21%	19.485	19.815	19.375
Mar 21, 2024	19.655	0.380	1.97%	19.275	19.745	19.275
Mar 20, 2024	19.165	0.160	0.84%	19.005	19.335	18.925
Mar 19, 2024	19.215	0.030	0.16%	19.185	19.215	18.885

Corbion N.V. Events

Time (UTC)	Country	Event
Friday, April 26, 2024
Time (UTC) 10:59	Country NL	Event Q1 2024 Corbion NV Interim Management Statement Release Q1 2024 Corbion NV Interim Management Statement Release Forecast - Previous -
Wednesday, May 15, 2024
Time (UTC) 10:59	Country NL	Event Corbion NV Annual Shareholders Meeting Corbion NV Annual Shareholders Meeting Forecast - Previous -
Friday, May 17, 2024
Time (UTC) 12:00	Country NL	Event Corbion NV Corbion NV Forecast - Previous -

View all events

Annual
Quarterly

	2022	2021	2020	2019	2018
Total revenue	1457.9	1070.8	986.5	976.4	897.2
Revenue	1457.9	1070.8	986.5	976.4	897.2
Cost of Revenue, Total	1131.5	801.8	710.6	704.1	639.1
Gross Profit	326.4	269	275.9	272.3	258.1
Total Operating Expense	1347.1	988.8	882.4	915.1	809.3
Selling/General/Admin. Expenses, Total	171.2	154.7	140.2	146.7	129.2
Research & Development	47.2	42.6	37.2	40.6	39.3
Unusual Expense (Income)	-2.8	-10.3	-5.6	23.7	1.7
Operating Income	110.8	82	104.1	61.3	87.9
Interest Income (Expense), Net Non-Operating	6	6.2	-15.2	-12.7	-12.7
Other, Net	-0.4	-1.7	-1.2	-3.9	-5.4
Net Income Before Taxes	116.4	86.5	87.7	44.7	69.8
Net Income After Taxes	90	78.3	73.1	25.8	54.3
Net Income Before Extra. Items	90	78.3	73.1	25.8	54.3
Net Income	90	78.3	73.1	25.8	54.3
Total Adjustments to Net Income
Income Available to Common Excl. Extra. Items	90	78.3	73.1	25.8	54.3
Income Available to Common Incl. Extra. Items	90	78.3	73.1	25.8	54.3
Dilution Adjustment
Diluted Net Income	90	78.3	73.1	25.8	54.3
Diluted Weighted Average Shares	58.9918	59.4	59.5	59.4	59.3
Diluted EPS Excluding Extraordinary Items	1.52564	1.31818	1.22857	0.43434	0.91568
Dividends per Share - Common Stock Primary Issue	0.476	0.476	0.476	0.476	0.476
Diluted Normalized EPS	1.71888	1.76094	1.1563	1.58923	0.95278

	Jun 2023	Dec 2022	Jun 2022	Dec 2021	Jun 2021
Total revenue	738	770.5	687.4	555.2	515.6
Revenue	738	770.5	687.4	555.2	515.6
Cost of Revenue, Total	565.6	602.4	529.1	427.3	374.5
Gross Profit	172.4	168.1	158.3	127.9	141.1
Total Operating Expense	684.4	718.8	628.3	543.5	445.3
Selling/General/Admin. Expenses, Total	91.5	89.6	81.6	76.8	77.9
Research & Development	24.4	24.1	23.1	26.2	16.4
Unusual Expense (Income)	2.9	2.7	-5.5	13.2	-23.5
Operating Income	53.6	51.7	59.1	11.7	70.3
Interest Income (Expense), Net Non-Operating	-14.3	-5.1	10.7	0	4.5
Net Income Before Taxes	39.3	46.6	69.8	11.7	74.8
Net Income After Taxes	28.1	38.2	51.8	10.8	67.5
Net Income Before Extra. Items	28.1	38.2	51.8	10.8	67.5
Net Income	28.1	38.2	51.8	10.8	67.5
Income Available to Common Excl. Extra. Items	28.1	38.2	51.8	10.8	67.5
Income Available to Common Incl. Extra. Items	28.1	38.2	51.8	10.8	67.5
Diluted Net Income	28.1	38.2	51.8	10.8	67.5
Diluted Weighted Average Shares	59.0343	59.0335	58.9501	59.8992	58.9008
Diluted EPS Excluding Extraordinary Items	0.47599	0.64709	0.87871	0.1803	1.14599
Dividends per Share - Common Stock Primary Issue	0	0.476	0	0.476	0
Diluted Normalized EPS	0.53189	0.68944	0.76336	0.47079	0.86756

Annual
Quarterly

	2022	2021	2020	2019	2018
Total Current Assets	654.3	504.5	385.1	372.5	349.6
Cash and Short Term Investments	58.2	42.2	51.6	45.7	47.1
Cash & Equivalents
Total Receivables, Net	249.2	212.4	143.8	155	144.4
Accounts Receivable - Trade, Net	210.5	163.2	123.7	124.2	119.6
Total Inventory	331.2	230	164.8	163.2	152.7
Prepaid Expenses	12	8.7	6.5	7.1	5.4
Other Current Assets, Total	3.7	11.2	18.4	1.5
Total Assets	1705.4	1341.1	1074.5	1091.1	965.8
Property/Plant/Equipment, Total - Net	729.5	532.9	406.5	433	368.9
Property/Plant/Equipment, Total - Gross	1460.7	1194.8	1027.4	1079.4	927.1
Accumulated Depreciation, Total	-731.2	-661.9	-620.9	-646.4	-558.2
Goodwill, Net	83.5	77.7	70.1	80.4	61.3
Intangibles, Net	80.1	80.2	95.6	92.5	77.9
Long Term Investments	27.9	23.2	15.3	16.6	18.7
Note Receivable - Long Term	99.4	94.8	73.7	67.2	62.3
Other Long Term Assets, Total	30.7	27.8	28.2	28.9	27.1
Total Current Liabilities	592.7	321	233.9	347.7	260
Accounts Payable	148.3	128	99.4	94.3	87.8
Notes Payable/Short Term Debt	0	0	0	0	0
Current Port. of LT Debt/Capital Leases	322	84.6	51.4	180.1	116.3
Other Current Liabilities, Total	68.6	64.6	45.7	34.8	55.9
Total Liabilities	1079.7	787	558.5	562	445.6
Total Long Term Debt	437.2	418.6	284.4	168.9	161
Long Term Debt	376	359.1	239.5	113	159.9
Capital Lease Obligations	61.2	59.5	44.9	55.9	1.1
Deferred Income Tax	30	25.4	15.3	13.4	17
Other Liabilities, Total	19.8	22	24.9	32	7.6
Total Equity	625.7	554.1	516	529.1	520.2
Common Stock	14.8	14.8	14.8	14.8	14.8
Additional Paid-In Capital	55.2	55.2	55.2	55.2	55.2
Retained Earnings (Accumulated Deficit)	528.7	467.2	441.6	403.8	414
Other Equity, Total	27	16.9	4.4	55.3	36.2
Total Liabilities & Shareholders’ Equity	1705.4	1341.1	1074.5	1091.1	965.8
Total Common Shares Outstanding	59.0129	58.9503	58.8717	58.8196	58.7646
Total Preferred Shares Outstanding
Cash	58.2	42.2	51.6	45.7	47.1
Accrued Expenses	53.8	43.8	37.4	38.5

	Jun 2023	Dec 2022	Jun 2022	Dec 2021	Jun 2021
Total Current Assets	648	654.3	626.5	504.5	420.5
Cash and Short Term Investments	58.1	58.2	73.7	42.2	38.3
Cash & Equivalents	58.1	58.2	73.7	42.2	38.3
Total Receivables, Net	281.4	264.9	263.2	231.2	203.2
Accounts Receivable - Trade, Net	218.8	210.5	216	163.2	146.9
Total Inventory	308.5	331.2	289.6	230	179
Total Assets	1723.2	1705.4	1596.3	1341.1	1167.6
Property/Plant/Equipment, Total - Net	766.6	729.5	642.3	532.9	433.1
Intangibles, Net	160.5	163.6	164.3	157.9	174.9
Long Term Investments	23.4	27.9	33.4	23.2	22.1
Note Receivable - Long Term	99.8	99.4	96.6	94.8	84.2
Other Long Term Assets, Total	24.9	30.7	33.2	27.8	32.8
Total Current Liabilities	627.3	592.7	503.1	321	273.1
Accounts Payable	129.4	148.3	145.2	128	86.2
Notes Payable/Short Term Debt	0	0	0	0	0
Current Port. of LT Debt/Capital Leases	399.8	322	240	84.6	89.4
Other Current Liabilities, Total	98.1	122.4	117.9	108.4	97.5
Total Liabilities	1102.3	1079.7	999.5	787	606.2
Total Long Term Debt	424.7	437.2	443.7	418.6	291.3
Long Term Debt	368.7	376	379.4	359.1	247.5
Capital Lease Obligations	56	61.2	64.3	59.5	43.8
Deferred Income Tax	28.9	30	30.4	25.4	15.8
Other Liabilities, Total	21.4	19.8	22.3	22	26
Total Equity	620.9	625.7	596.8	554.1	561.4
Common Stock	14.8	14.8	14.8	14.8	14.8
Additional Paid-In Capital	55.2	55.2	55.2	55.2	55.2
Retained Earnings (Accumulated Deficit)	550.9	555.7	526.8	484.1	491.4
Total Liabilities & Shareholders’ Equity	1723.2	1705.4	1596.3	1341.1	1167.6
Total Common Shares Outstanding	59.2731	59.0129	59.0129	58.9503	58.952
Other Current Assets, Total		0		1.1

Annual
Quarterly

	2022	2021	2020	2019	2018
Net income/Starting Line	110.8	82	104.1	25.8	54.3
Cash From Operating Activities	39	22.4	109	114.4	99.5
Cash From Operating Activities	76.4	64.1	60.3	61.5	42
Non-Cash Items	-3.4	-7.3	-8.7	49.9	32.6
Cash Taxes Paid	18.3	25.5	10.7	4	9.6
Cash Interest Paid	18.1	13	10.8	10	8.7
Changes in Working Capital	-144.8	-116.4	-46.7	-22.8	-29.4
Cash From Investing Activities	-199.1	-119.4	-76.9	-104.8	-87.6
Capital Expenditures	-235.8	-148.7	-88.9	-76.2	-60.1
Other Investing Cash Flow Items, Total	36.7	29.3	12	-28.6	-27.5
Cash From Financing Activities	173.9	85.9	-23.9	-12	-4.3
Total Cash Dividends Paid	-33	-33	-33	-32.9	-32.9
Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net	221.8	118.9	9.1	20.9	28.6
Net Change in Cash	16	-9.4	5.9	-1.4	9
Foreign Exchange Effects	2.2	1.7	-2.3	1	1.4
Financing Cash Flow Items	-14.9

	Dec 2022	Jun 2022	Dec 2021	Jun 2021
Net income/Starting Line	110.8	59.1	82	70.3
Cash From Operating Activities	39	18	22.4	15.6
Cash From Operating Activities	76.4	36.3	64.1	30.3
Non-Cash Items	-3.4	-7.2	-7.3	-28.3
Cash Taxes Paid	18.3	3.8	25.5	11.5
Cash Interest Paid	18.1	7.3	13	6.2
Changes in Working Capital	-144.8	-70.2	-116.4	-56.7
Cash From Investing Activities	-199.1	-86.6	-119.4	-29.2
Capital Expenditures	-235.8	-112.7	-148.7	-52.8
Other Investing Cash Flow Items, Total	36.7	26.1	29.3	23.6
Cash From Financing Activities	173.9	97.5	85.9	-0.2
Total Cash Dividends Paid	-33	-33	-33	-33
Issuance (Retirement) of Debt, Net	221.8	145.4	118.9	32.8
Foreign Exchange Effects	2.2	2.6	1.7	0.5
Net Change in Cash	16	31.5	-9.4	-13.3
Financing Cash Flow Items	-14.9	-14.9

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

1:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Corbion Company profile

About Corbion NV

Corbion NV is a company based in the Netherlands that is active in the field of biochemical ingredients. The Company's products include lactic acid derivatives, emulsifiers, functional enzyme blends, minerals and vitamins, among others. It operates through two business lines: Ingredient Solutions, divided into business segments Food and Biochemicals, as well as Innovation Platforms. The Food segment develops preservation ingredients and microbial spoilage prevention products for the baking, meat, dairy, confectionery and beverage industries, and the Biochemicals segment produces bio-based chemicals derived from renewable resources such as sugar or starch. The Innovation Platforms segment creates new biotechnology business platforms, such as the poly lactic acid (PLA) bioplastic or its algae ingredients business. The Company operates production sites in the United States, Brazil, Spain, the Netherlands and Thailand, and markets its products through a global network of retail offices.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Corbion NV revenues increased 9% to EUR1.07B. Net income increased 7% to EUR78.3M. Revenues reflect Sustainable Food Solutions segment increase of 7% to EUR584.2M, Lactic Acid and Specialties segment increase of 13% to EUR312.3M, Incubator segment increase from EUR13.4M to EUR30.7M, Asia segment increase of 13% to EUR193.8M, US segment increase of 4% to EUR499.2M.

Equity composition

04/2009, Stock Dividend, 1 new share for every 21 shares held.

Industry:

Specialty Chemicals (NEC)

Piet Heinkade 127
AMSTERDAM
NOORD-HOLLAND 1019 GM
NL

Income Statement

Annual
Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024